Confounding by indication in non-experimental evaluation of vaccine effectiveness: the example of prevention of influenza complications.
about
Influenza vaccination: policy versus evidenceThe role of 'confounding by indication' in assessing the effect of quality of care on disease outcomes in general practice: results of a case-control studyFrequency and impact of confounding by indication and healthy vaccinee bias in observational studies assessing influenza vaccine effectiveness: a systematic reviewMethodological challenges in measuring vaccine effectiveness using population cohorts in low resource settingsEffectiveness of influenza vaccination for preventing influenza-related complications in people with asthma: a systematic review protocolInfluenza vaccine effectiveness in the elderly based on administrative databases: change in immunization habit as a marker for biasNear real-time surveillance for influenza vaccine safety: proof-of-concept in the Vaccine Safety Datalink Project.Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada.Are there any differences in clinical and laboratory findings on admission between H1N1 positive and negative patients with flu-like symptoms?Effectiveness of seasonal influenza vaccine against pandemic (H1N1) 2009 virus, Australia, 2010Effectiveness of a MF-59™-adjuvanted pandemic influenza vaccine to prevent 2009 A/H1N1 influenza-related hospitalisation; a matched case-control study.Effectiveness and safety of the A-H1N1 vaccine in children: a hospital-based case-control study.The potential effect of temporary immunity as a result of bias associated with healthy users and social determinants on observations of influenza vaccine effectiveness; could unmeasured confounding explain observed links between seasonal influenza vEstimating vaccine effectiveness against severe influenza in England and Scotland 2011/2012: applying the screening method to data from intensive care surveillance systems.Do influenza and pneumococcal vaccines prevent community-acquired respiratory infections among older people with diabetes and does this vary by chronic kidney disease? A cohort study using electronic health recordsSeasonal Influenza Vaccine Effectiveness in the community (SIVE): protocol for a cohort study exploiting a unique national linked data set.Mortality in members of HIV-1 serodiscordant couples in Africa and implications for antiretroviral therapy initiation: results of analyses from a multicenter randomized trial.Vaccines for the prevention of seasonal influenza in patients with diabetes: systematic review and meta-analysis.Effectiveness of influenza vaccine in aging and older adults: comprehensive analysis of the evidence.Effectiveness of adjuvanted influenza vaccination in elderly subjects in northern Italy.Factors influencing choice of surgical route of repair of genitourinary fistula, and the influence of route of repair on surgical outcomes: findings from a prospective cohort study.Longitudinal Trends in Hypertension Management and Mortality Among Octogenarians: Prospective Cohort StudyAssociation of proteinuria with race, cause of chronic kidney disease, and glomerular filtration rate in the chronic kidney disease in children studyInfluenza vaccination and fetal and neonatal outcomes.Influenza vaccine effectiveness: best practice and current limitations of the screening method and their implications for the clinic.Cardiovascular safety of sulphonylureas: over 40 years of continuous controversy without an answer.Effectiveness of seasonal influenza vaccination in patients with diabetes: protocol for a nested case-control studyExternal adjustment of unmeasured confounders in a case-control study of benzodiazepine use and cancer risk.Childhood and adolescent influenza vaccination in Europe: A review of current policies and recommendations for the future.Influenza vaccine effectiveness estimates in Croatia in 2010-2011: a season with predominant circulation of A(H1N1)pdm09 influenza virus.Quantifying the potential role of unmeasured confounders: the example of influenza vaccination.RCTs and observational studies to determine the effect of prophylaxis in severe haemophilia.Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007.Analysis of recruitment in a pragmatic observational study on C-reactive protein point-of-care testing in primary care.Magnitude of potential biases in a simulated case-control study of the effectiveness of influenza vaccination.The risk of Guillain-Barré syndrome associated with influenza A (H1N1) 2009 monovalent vaccine and 2009-2010 seasonal influenza vaccines: results from self-controlled analyses.
P2860
Q24678358-5C4A6816-A7E1-464F-8951-7CA0224F0819Q24800184-360CD05F-6F33-4A03-AEAB-4E13A1A62627Q26782188-695D7F5A-6ADD-4040-BC9F-EAE4E54E9375Q26800157-A88D1490-BA55-44DF-AD12-5D48E7CD0BFAQ28077038-DB42C0CA-CDFC-44F3-A2F3-0FDDF48DA3C0Q28742116-405D7A91-E21B-407A-BA41-B81C3FF029DEQ30383245-58047043-891D-48A9-AD0C-FEE6E6BF40FEQ30388012-51339FB9-452C-47F9-B227-DE41A43C5F48Q30398353-8A4A91DF-6069-4007-A990-3EEA8C8BA544Q30404923-36D9D9F1-A495-4056-A51D-01715E6B9FCFQ30404989-D9B5E898-CD06-4E8A-BDC2-B782BB823D06Q30408530-CD2ECCD9-20BE-48F8-8257-0E50C81736A4Q30418277-A4D5E836-C482-4A0F-8F6C-60E83E3248BCQ30617335-4A4E7C87-248E-4EE8-BD61-BA98A9900D95Q33552701-02DB48C0-A5A1-48DE-836E-9849DDE9E5AFQ34197731-C6CDDF96-970C-4EE2-8901-7AEB73969340Q34468239-DF946C9E-9BE4-4204-B50E-5F84CD1AB549Q35215500-EC03F7CA-E5CD-48B4-8322-62995839F44EQ35797338-66187D96-602F-4C5B-A96A-E8CDF02DD87FQ36248959-FD2D9FB1-7E6B-41BA-B280-304C1212B845Q36315306-EF17061F-08C2-4877-94A6-50923B257CEEQ36988076-2CE49271-58C2-4B69-AB7E-84174711C473Q37152477-5015458E-DDBC-41EA-956B-3A3348EE03EDQ38160249-95C33DDE-662D-4E4F-BFBB-DC559DEB819EQ38221641-1FC4E8FB-C63A-4773-AC79-1AF41C726E9CQ38364806-91E408C7-020D-4BA5-A05F-25FCDC3464FBQ38618072-EF2B20BB-0387-48E0-A8F7-10A2949ED1D5Q38733974-CF86407E-6FC4-4787-910B-D51EF323C014Q38734736-44389641-5752-4DC5-9457-638ECCF971FFQ41612054-44275187-CED7-4E78-9822-696DCC89B6BEQ45786504-565C2508-DC9B-4F1A-900B-A121CA30EC95Q45869275-3606FA83-C049-43FD-A379-153F76B0D2F2Q48071872-0330FEA0-54F2-4D05-AF1F-49C1EEFAB076Q51598319-1158FDCF-9669-41EF-998C-C05209D50F65Q53091538-CFC56E0C-BF00-40E9-8EF9-C0D89BB120EAQ53645955-A800A9CF-3F0D-47AF-9D3B-9B391D0DF70E
P2860
Confounding by indication in non-experimental evaluation of vaccine effectiveness: the example of prevention of influenza complications.
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Confounding by indication in n ...... on of influenza complications.
@ast
Confounding by indication in n ...... on of influenza complications.
@en
type
label
Confounding by indication in n ...... on of influenza complications.
@ast
Confounding by indication in n ...... on of influenza complications.
@en
prefLabel
Confounding by indication in n ...... on of influenza complications.
@ast
Confounding by indication in n ...... on of influenza complications.
@en
P2093
P2860
P356
P1476
Confounding by indication in n ...... on of influenza complications.
@en
P2093
P2860
P304
P356
10.1136/JECH.56.12.951
P577
2002-12-01T00:00:00Z